Akemi Sato

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction

Eisaburo Sueoka, Naoko Sueoka, Kentaro Iwanaga et al. · Lung Cancer · 2004 · 77 citations

Biomarker (Medicine), Oncology, Medicine +11

Application of a Highly Sensitive Detection System for Epidermal Growth Factor Receptor Mutations in Plasma DNA

Tomomi Nakamura, Naoko Sueoka‐Aragane, Kentaro Iwanaga et al. · Journal of Thoracic Oncology · 2012 · 76 citations · Full text

Plasma Dna, Engineering, Reporter Gene Assay +11

2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent

Masako Yokoo, Yasushi Kubota, Keiichi Motoyama et al. · PLoS ONE · 2015 · 76 citations · Full text

Hematological Malignancy, Tumor Biology, Medicinal Chemistry +15

A Noninvasive System for Monitoring Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors with Plasma DNA

Tomomi Nakamura, Naoko Sueoka‐Aragane, Kentaro Iwanaga et al. · Journal of Thoracic Oncology · 2011 · 72 citations · Full text

Plasma Dna, Signal Transduction, Noninvasive System +7